LB Pharmaceuticals Inc Common Stock

Share · US50180M1080 · LBRX (XNAS)

Overview

Analyst Grade Summary

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

No Price

13.03.2026 20:57

Current Prices from LB Pharmaceuticals Inc Common Stock

Exchange	Ticker	Currency	Last Trade	Price	Daily Change
NASDAQ	LBRX	USD	13.03.2026 20:57	26,00 USD	1,06 USD +4,25 %
IEX	LBRX	USD	13.03.2026 19:59	25,72 USD	0,78 USD +3,13 %

Share Float & Liquidity

Free Float 74,30 %

Shares Float 18,8 M

Shares Outstanding 25,3 M

Company Profile for LB Pharmaceuticals Inc Common Stock Share

Clinical‑stage biopharmaceutical company developing novel therapies for neuropsychiatric diseases (e.g. schizophrenia, bipolar depression). Lead candidate is LB‑102, a methylated derivative of amisulpride.

AI Analysis of LB Pharmaceuticals Inc Common Stock

Click any analysis below to get instant AI insights from finAgent

Latest AI Analyses of LB Pharmaceuticals Inc Common Stock

No AI threads available for this company yet.

Company Data

Name LB Pharmaceuticals Inc Common Stock

Company LB Pharmaceuticals Inc Common Stock

Symbol LBRX

Website https://lbpharma.us

Primary Exchange

NASDAQ

ISIN US50180M1080

Asset Class Share

Sector Healthcare

Industry Biotechnology

CEO Heather D. Turner

Market Capitalization 649 Mio

Country United States of America

Currency USD

Employees 0,0 T

Address One Pennsylvania Plaza, 10119 New York

IPO Date 2025-09-11

Ticker Symbols

Name	Symbol
NASDAQ	LBRX

More Shares

Investors who hold LB Pharmaceuticals Inc Common Stock also have the following shares in their portfolio:

AMGEN 21/53 Bond

GLENC.CAP.F. 20/27 MTN Bond

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog